Company Pain Therapeutics, Inc. Nasdaq
Equities
US69562K5065
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01/98/01 |
Eric Schoen
DFI | Director of Finance/CFO | 55 | 01/18/01 |
James Kupiec
CTO | Chief Tech/Sci/R&D Officer | - | 04/21/04 |
Michael Zamloot
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Director/Board Member | 65 | 01/98/01 | |
Robert Cook
LAW | General Counsel | 60 | 01/22/01 |
Michael Marsman
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01/98/01 |
Robert Gussin
BRD | Director/Board Member | 86 | 01/03/01 |
Patrick Scannon
BRD | Director/Board Member | 76 | 07/07/07 |
Director/Board Member | 92 | 01/98/01 | |
Richard Barry
BRD | Director/Board Member | 65 | 11/21/11 |
Director/Board Member | 65 | 01/98/01 | |
Claude Nicaise
BRD | Director/Board Member | 71 | 07/12 |
Robert Anderson
BRD | Director/Board Member | 58 | 07/12 |
Pierre Gravier
BRD | Director/Board Member | 39 | 07/12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 43,245,758 | 40,141,808 ( 92.82 %) | 0 | 92.82 % |
Company contact information
Cassava Sciences, Inc.
6801 North Capital of Texas Highway Suite 300
78731, Austin
+512 501 2444
http://www.cassavasciences.comSector
1st Jan change | Capi. | |
---|---|---|
-2.90% | 102B | |
+1.49% | 96.09B | |
+2.13% | 22.28B | |
-17.07% | 21.4B | |
-9.03% | 18.14B | |
-39.98% | 17.02B | |
-14.17% | 16.09B | |
+6.12% | 13.83B | |
+33.19% | 11.97B |